Lufax Holding (NYSE:LU) is back in focus after multiple law firms announced investigations related to the company’s January 2025 disclosure about a proposed auditor removal and a potential delay to its 2024 annual report.
See our latest analysis for Lufax Holding.
The governance concerns around the proposed auditor removal and possible reporting delay come on top of a weak trading stretch, with a 30 day share price return of 16.26% decline and a 1 year total shareholder return of 23.42% loss, pointing to fading momentum rather than a near term rebound.
If these headlines have you reassessing your options, it could be a good moment to broaden your watchlist with our screener of 20 top founder-led companies and see what else catches your eye.
With the share price under pressure, annual revenue at CN¥28,363.981 and a net loss of CN¥3,870.62, plus a discount to analyst price targets, is this weakness a potential entry point, or is the market already pricing in future growth?
Preferred Price-to-Sales of 0.5x: Is it justified?
On a P/S of roughly 0.5x against annual revenue of CN¥28,363.981 and a last close of $2.42, Lufax Holding is trading at a clear discount to peers and its own estimated fair ratio.
The P/S multiple compares the company’s market value to its revenue, which can be useful when earnings are negative or volatile. For Lufax, that matters because it is currently loss making, with a net loss of CN¥3,870.62 and a negative return on equity of 4.31%, so profit based multiples are less informative right now.
Simply Wall St’s checks suggest Lufax is trading at what appears to be good value on this metric, with a 0.5x P/S compared to an estimated fair P/S of 1.8x, as well as a peer and broader US Consumer Finance industry average of 1.3x. That combination indicates a sizable gap between the current market valuation and where the multiple could move if sentiment and fundamentals align with those benchmarks.
Explore the SWS fair ratio for Lufax Holding
Result: Price-to-Sales of 0.5x (UNDERVALUED)
However, the proposed auditor removal, potential reporting delay and recent multi-year share price losses near 90% could all keep sentiment fragile and the discount in place.
Find out about the key risks to this Lufax Holding narrative.
Next Steps
If this has left you unsure whether the current weakness is justified, consider acting while the details are fresh and weigh the positives too, starting with 2 key rewards.
Looking for more investment ideas?
If this situation has sharpened your focus, do not stop here; broaden your research now so you are not relying on a single story.
- Target value first by scanning our list of 49 high quality undervalued stocks that pair solid fundamentals with prices the market may be overlooking.
- Prioritise resilience by checking 63 resilient stocks with low risk scores, where companies score well on stability so short term noise is less likely to derail your thesis.
- Get ahead of the crowd by reviewing our screener containing 24 high quality undiscovered gems, highlighting quality businesses that are not yet on every investor’s radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com